<DOC>
	<DOC>NCT02307292</DOC>
	<brief_summary>This is a prospective, non-randomized post market surveillance registry designed to document the clinical Performance in Routine clinical practice of the POLARIS Peripheral Vascular Self Expanding Stent System</brief_summary>
	<brief_title>Prospective, Post Market Surveillance Q3-registry (POLARIS)</brief_title>
	<detailed_description />
	<mesh_term>Peripheral Arterial Disease</mesh_term>
	<criteria>Age &gt;18 years Single target de novo superficial femoral artery lesion (angiographic evidence of &gt;50% Stenosis or occlusion) by visual estimate Rutherford category IIIV At least one patent outflow artery to the ankle. Patient signed the informed consent Patient with acute or subacute Thrombus Patients with hyperkoagulopathy Patients with Stenosis or occlusion where lesion crossing with guide wire is not possible Pregnancy or positive pregnancy test Previous enrolment in this Trial or other industrial Trials PatientÂ´s inability to fully cooperate with the registry protocol Patient with cancer Treatment (life expectancy less than 2 years) Patients with renal failure</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2015</verification_date>
	<keyword>Superficial femoral artery</keyword>
	<keyword>Self Expanding Stent System</keyword>
</DOC>